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Central nervous system infections and the neurosurgeon: A perspectiveCentral nervous system (CNS) infections and their sequalae still
constitute a major source of morbidity. In the recent past, the intro-
duction of newer broad spectrum antibiotics, improved imaging
technology and intensive care facilities have signiﬁcantly altered
the natural history of central nervous system infections. It is well
known that brain does not have an immune system of its own
and an intact blood brain barrier is largely impervious to infections.
It is exempliﬁed by the fact that CNS infections are uncommon
compared to a large proportion of patients inﬂictedwith septicemia
or pyemia.
Brain abscess is one of the most serious diseases of the central
nervous system. This condition is more common among men –
twice to three times, and morbidity rate is highest in fourth decade
of the life.1,2 Brain abscess still continues to be a signiﬁcant problem
in the developing world due to large scale poverty, illiteracy and
lack of hygiene. Brain abscess resulting from acute bacterial menin-
gitis is rare. Otogenic cerebellar/temporal lobe abscesses are
common in children due to chronic active suppurative otitis media
while fungal abscesses are seen more commonly in adult patients
with immunocompromised status.
Advanced magnetic resonance (MR) imaging has revolution-
ized the diagnosis of brain abscess. Diffusion weighted imaging
(DWI) usually show restricted diffusion (bright signal) that helps
to differentiate abscesses from necrotic neoplasms, which are
not usually restricted,3 although not all abscesses follow this
rule. DWI has a sensitivity and speciﬁcity of over 90% for distin-
guishing epidermoid which has low apparent diffusion coefﬁcient
(ADC) from arachnoid cyst (high ADC) and distinguishing abscess
(low ADC) from necrotic tumor (high ADC). Magnetic resonance
spectroscopy has been shown to be speciﬁcally beneﬁcial in differ-
entiating between brain abscesses and other cystic lesions, which
can be used to expedite implementation of the appropriate anti-
microbial therapy.4,5 Proton magnetic resonance spectroscopy
(1H-MRS) can detect a choline resonance that is largely due to
glycerophosphocholine. 1H-MRS is a safe, non-invasive imaging
modality and can accurately differentiate between necrotic/cystic
tumor and cerebral abscesses.5 1H-MRS can also provide valuable
information regarding the etiology of an abscess, as well as, its
response to any medical or surgical treatment.
The pia arachnoid membrane tends to serve as an effective
barrier to the spread of infection into the brain tissue. The abscess
wall is crucial in maintaining the integrity of the brain function
and limits the expansion of the infective process. At 3–4 weeks,
the abscess capsule becomes thick and is amenable to excision.
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eradicate the infection and the abscess wall involutes itself, some-
times leaving no evidence of its occurrence. In most instances, aspi-
ration of the purulent material is sufﬁcient to initiate the healing of
abscess. However, surgical excision becomesmandatory if the pus is
thick and in multiloculated abscesses. Urgent evacuation of abscess
is required for subdural empyema and cerebellar abscess.
Computed tomography (CT) guided stereotactic aspiration is partic-
ularly advocated in management of deep-seated abscesses,
multiple abscesses, and abscesses located in eloquent areas of the
brain. The technique of ﬁber tracking based on diffusion tensor
imaging offers the unique possibility of localizing the white matter
pathways of the brain in vivo.6 In patients with cerebral tumors or
space-occupying lesions of the brain, these pathways are often
damaged or signiﬁcantly displaced. Knowledge of the exact location
of the lesion with respect to clinically eloquent white matter path-
ways is of great value to the neurosurgeon in planning the appro-
priate surgical strategy. A traumatic brain abscess may require
craniotomy to remove foreign material or bone chips. Cerebellar
or brain stem abscesses are often indication for posterior fossa
craniotomy since there is high risk of brain herniation due to the
small volume of posterior fossa.1,2 Periventricular brain abscesses
often require craniotomy given the risk of intraventricular rupture.
A ventriculostomy placement is indicated for signiﬁcantly elevated
intracranial pressure. There is no well-controlled, randomized clin-
ical study evaluating the use of corticosteroids for controlling the
cerebral edema surrounding brain abscess. However, corticoste-
roids are recommended perioperatively for reducing intracranial
pressure and avoiding acute brain herniation.7 Tuberculous brain
abscess is rare and can be difﬁcult to differentiate from pyogenic
abscess. It results from the caseation of tuberculoma and pus forma-
tion due to polymorphnuclear inﬁltration. The wall is thicker than
pyogenic abscess. Antituberculous therapy along with aspiration
of the abscess is advocated. Stereotactic aspiration of the abscess
can be performed but there is a risk of neurological worsening
and ﬂaring up of tuberculous lesion and hence caution is advised.8
There is a resurgence of multidrug resistant tuberculosis due to
high prevalence of Human Immunodeﬁciency virus (HIV) and other
immunodeﬁciency states. Tuberculosis in HIV infected patients
should be treated within specialist units by physicians with exper-
tise in both HIV and tuberculosis, or in a combined approach
between HIV and tuberculosis experts.9
The most important factors inﬂuencing mortality from intracra-
nial abscess are age and neurological condition of the patient at the
time of admission. Delays in hospitalization, focal neurologicd. All rights reserved.
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betes, and Glasgow Coma Scale less than 12 are associated with
death and permanent neurologic deﬁcits because of brain
abscesses.1 The treatment of brain abscess necessitates amultidisci-
plinary approach, including neuroradiological evaluation, surgical
intervention, use of antibiotics and eradication of primary infected
foci. Despite the usage of antibiotics, the incidence of brain abscess
is exceedingly low. Broad spectrum coverage including a fourth-
generation cephalosporin, metronidazole, and vancomycin, based
on predisposing factors can be administered till the pus culture
report is available. Carbapenems can be used in place of the combi-
nation of cephalosporins and metronidazole. Once a causative
microorganism is identiﬁed, antimicrobial therapy can be tailored.
Similar to meningitis, the choice of optimal therapy is determined
by antimicrobial penetration to the brain parenchyma and in vitro
susceptibilities of the pathogens. While at least 6–8 weeks of
parenteral therapy has been traditionally given for bacterial brain
abscesses, there is no convincing data supporting the optimal dura-
tion of therapy. Duration of antimicrobial therapy should be deter-
mined individually, based on the size of abscess, combination of
surgical treatment, causative organism and response to treatment.
The treatment of tuberculous meningitis (TBM) is predomi-
nantly antituberculous chemotherapy. Empirical anti-tuberculosis
therapy should be started promptly in all patients in whom the
diagnosis of TBM is suspected since delay is strongly associated
with high mortality and morbidity. There is no need to wait for
microbiological or molecular diagnostic conﬁrmation. TBM should
be suspected if there is a CSF leucocytosis (predominantly lympho-
cytes), the CSF protein is raised, and the CSF:plasma glucose is
<50%.9 A tissue diagnosis (by histopathology and mycobacterial
culture) should be attempted whenever possible, either by biopsy
of the lesion itself, or through diagnostic sampling from extra-
neural sites of disease. The role of CSF diversion in TBM needs to
be objectively evaluated since the symptomatology of meningitis
frequently overlaps symptoms of raised intracranial procedure. In
addition, fundus exam in a patient with TBM can sometimes be
misleading due to arachnoiditis surrounding the optic apparatus.
Hence a close clinical follow-up is needed to determine the appro-
priate time for cerebrospinal ﬂuid (CSF) diversion procedure in
event of clinical decompensation. The Vellore grading system
provides a fair guideline for CSF diversion.10 CSF diversion proce-
dure should be performed for chronic symptomatic or progressive
hydrocephalus. In grade IV TBM, CSF diversion is contemplated only
if there is clinical improvement following external ventricular drain
insertion. However, Srikantha et al.11 in a retrospective study
comprising of 95 patients conclude that direct VP shunt placement
is an effective option in patients with Grade IV TBM with hydro-
cephalus. Early shunt deployment is known to prevent long-term
neurological sequelae.12,13 An inadvertent delay in the decision
making process for CSF diversion can have a deleterious effect on
the neuropsychological and cognitive outcome. Endoscopic third
ventriculostomy (ETV) is performed in patients who have been
treated with antituberculous therapy for at least 4 weeks or in
whom the disease is burnt out or onset of hydrocephalus is late
in the disease.14 It is fraught with risks since the ﬂoor of the third
ventricle may be thick and opaque, thus increasing the risk of injury
to basilar artery and its perforators. ETV in TBM and hydrocephalus
is technically demanding procedure and requires considerable skill
and experience for a successful outcome. The grade at presentation
is the best and most consistent predictor of outcome following
shunt surgery in patients with TBM.
Fungal infections of the central nervous system (CNS) are rare in
the general population and are most frequently encountered in
immunocompromised patients such as those with acquired immu-
nodeﬁciency syndrome or after organ transplantation.1 Fungalbrain abscesses caused by yeast (eg, Candida spp, Cryptococcus
spp), dimorphic fungi (eg, Histoplasma spp, Coccidioides spp, Blas-
tomyces spp), and molds (eg, Aspergillus spp, Rhizopus) are associ-
ated with immunocompromised states, and in the case of
zygomycosis, poorly controlled diabetes.1,2 Due to the lack of
inﬂammatory response, neuroradiological ﬁndings are often
nonspeciﬁc and are frequently mistaken for tuberculous menin-
gitis, pyogenic abscess or brain tumor. Intracranial fungal infections
are being identiﬁed more frequently due to the increased incidence
of Acquired immunodeﬁciency syndrome (AIDS) patients, better
radiological investigations, more sensitive microbiological tech-
niques and better critical care of moribund patients. Although
almost any fungus may cause encephalitis, cryptococcal meningo-
encephalitis is most frequently seen, followed by aspergillosis and
candidiasis. The prognosis of fungal meningitis is dismal. Surgical
decompression for large fungal granulomas, especially aspergillus
can produce transient improvement due to reduction in the intra-
cranial pressure but eventual outcome is uniformly poor.1,2 Crypto-
coccosis is a global invasive mycosis associated with signiﬁcant
morbidity and mortality. Cryptococcal meningoencephalitis is
divided into three risk groups viz. human immunodeﬁciency
virus (HIV)-infected individuals, organ transplant recipients, non-
HIV-infected and nontransplant hosts.15 There are speciﬁc recom-
mendations for other unique risk populations, such as children,
pregnant women, persons in resource-limited environments, and
thosewith Cryptococcus gattii infection. There is a special emphasis
on potential complications in management of cryptococcal infec-
tion, including increased intracranial pressure, immune reconstitu-
tion inﬂammatory syndrome (IRIS), drug resistance, and
cryptococcomas. The management principles include induction
therapy for meningoencephalitis using fungicidal regimens, such
as a polyene and ﬂucytosine, followed by suppressive regimens
using ﬂuconazole, importance of early recognition and treatment
of increased intracranial pressure and/or IRIS; and the use of lipid
formulations of amphotericin B regimens in patients with renal
impairment. Cryptococcosis can be managed successfully in the
vast majority of patients if the diagnosis is made early, treatment
is instituted according to the guidelines and underlying disease is
controlled.15 CNS cryptococcoma is rare in immunocompetent
patients.16,17 The symptomatology is similar to CNS tumors and
can be difﬁcult to diagnose preoperatively. Ring-shaped enhance-
ment of mass lesions with or without cystic changes in the MR
imaging may indicate cryptococcoma, but deﬁnitive diagnosis
relies on pathological study of the lesion specimen. Open surgery
and anti-fungal therapy is the treatment of choice.16,17 The prog-
nosis of cryptococcoma is largely determined by its location. There
are many controversies and unresolved issues in neurosurgical
practice like minimal invasive versus total resection of the fungal
granuloma, fungal intracranial presentation in immunocompetent
patients, high mortality of fungal cases managed without anti-
fungal cover, duration of antibiotics, optimal time and mode of
hydrocephalus treatment.16
Hydatid disease affects a large population around the world and
has a potential to cause considerable mortality andmorbidity, if not
handled properly.18,19 The epidemiology of echinococcosis is inﬂu-
enced by agricultural, educational, economic, medical and cultural
factors. Infection of the central nervous system is rare, and the
mainstay of treatment is surgical excision of the intracranial or
spinal cyst, when present. Despite all the advances in imaging tech-
niques and therapeutic methods, central nervous system hydatido-
sis remains difﬁcult to cure and patient outcomes are not
satisfactory especially in case of spinal involvement due to the
high incidence of recurrence.19 Cranial hydatid withmany daughter
cysts is difﬁcult to excise without spillage and recurrence is an inev-
itable complication. At surgery, a large scalp ﬂap should be raised
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of the cyst with meticulous technique and follow the Dowling-
Orlando technique. In children, although the complications
following cerebral hydatid cyst surgery in children are varied,
they are not usually fatal, if appropriate surgical therapy is
utilized.20 Surgical removal of the clinically symptomatic cysts
and treatment with antihelminthics are only palliative. Prevention
is the best strategy and has been successful in New Zealand,
Australia, and China. In India, the deﬁnitive host is the domestic
dog and the intermediate hosts are sheep, goat, and cattle. In a study
on the incidence of hydatid infestation in intermediate hosts in Kur-
nool the positivity of goats, sheep, and cattle was 16.96, 21.75, and
60.94%, respectively.21 The positivity in dogs in Kurnool region was
33.3%. These facts emphasize the need to control the disease in
intermediate hosts and deﬁnitive hosts to contain the hydatid
disease. Surveillance of dogs and periodic test of the stools is para-
mount for effective treatment. The access to raw offal at slaughter
houses and farms should be prevented to effectively control the
incidence of hydatidosis.21,22
Neurocysticercosis is the commonest parasitic infestation of the
brain. About 50million peopleworldwide suffer from this disease.23
In India; there are one million patients with active epilepsy due to
neurocysticercosis. Nearly two-thirds of the patients in India harbor
only one degenerating cyst – the solitary cysticercus granuloma
which is the commonest cause of focal seizures in Indian patients.23
Mostly, the therapy of NCC is medical and symptomatic. Cysticidal
drugs such as praziquantel and albendazole are also used in the
treatment of NCC. Surgery is reserved for selected patients with
NCC and plays a minor role in the management of the disease.23,24
It is usually recommended for intraventricular cysts, hydrocephalus,
large cisternal cysts, largeparenchymal cysts andwhenthediagnosis
is not certain on imaging studies. Endoscopic surgery is the proce-
dure of choice for intraventricular cysts.24 Incompletelyexcised cysts
and cysts or granulomas in locations such as the spinal cord can be
treated with steroids and albendazole. Although hydrocephalus is
treated with a ventriculo-peritoneal shunt but the incidence of
frequent obstructions and multiple revisions is high. The outcome
for patients with intraventricular and parenchymal cysts is usually
good except for patients with hydrocephalus associated with
cisternal or racemose cysts.23,24 Themortality is high in cysticercotic
meningitis. The possible strategies to control cysticercosis include
health education emphasizing the need for hygienic practices such
as hand washing after defecation and before eating, mass chemo-
therapy for taeniasis and vaccination of pigs. Eradication of the
disease is possible but socio-economic factors prevent achievement
of this goal in the near future in several under-developed regions of
the world.
Pneumocystis carinii (jiroveci) pneumonia has been one of the
most important opportunistic infections in AIDS patients.25
Prophylaxis of Pneumocystis pneumonia is necessary for patients
requiring corticosteroids for more than 1 month.25,26
Postoperative wound infection (PWI) after intracranial neuro-
surgery is a signiﬁcant issue in any neurosurgical unit with
a substantial potential for morbidity and mortality, if not addressed
proactively. The reported incidence of PWI after intracranial neuro-
surgery ranges from 1% to 8% in published series.27 PWI after intra-
cranial neurosurgery was nearly 3 times more likely in European
versus North American studies. It highlights the need for future
prospective studies to provide evidence-based explanations for
these differences. Respiratory tract infections were common in
patients following traumatic brain injury who underwent surgery
with Acinetobacter spp. being the emerging offending patho-
gens.27,28 Device-related postoperative communication of the CSF
and the environment is a signiﬁcant risk factor for and develop-
ment of meningitis in particular. Malignancy is an independentrisk factor for surgical site infection in selected patient populations,
hyperglycemia has been shown to increase the risk of surgical site
infection whereas stringent glucose control has improved
outcomes.29 Till date, there is no study which has focussed on
whether surgical site infection in patients with brain tumors under-
going resection is associated with hyperglycemia. Glucose level is
not a signiﬁcant factor in development of postoperative surgical
site infection if duration of surgery and adherence to antibiotic
prophylaxis is monitored. However, duration of surgery is signiﬁ-
cantly associated with postoperative surgical site infection.29
In conclusion, central nervous system infections still continue to
be a formidable challenge despite introduction of newer and effec-
tive antimicrobial chemotherapy. MR imaging should be judiciously
used to differentiate brain abscess from tumors and cysts. Prompt
institution of intravenous antibiotics and therapeutic drainage of
brain abscess should be performed. CSF diversion procedures for
postmeningitic hydrocephalus should be performed timely to
prevent long-term neurological and cognitive decline. Tuberculosis,
Hydatid disease, cryptococcosis, neurocysticercosis, HIV-related
CNS infections and postoperative wound infection are still major
issues in developing countries. Prevention including health educa-
tion and good hygienic practices are of paramount importance.Conﬂict of interest
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